Human IgG antibody Laboratories manufactures the spike protein mutation of virus reagents distributed by Genprice. The Spike Protein Mutation Of Virus reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Spike products are available in stock. Specificity: Spike Category: Protein Group: Mutation Of
Human Rabies Virus Antibody IgG (RV-IgG) ELISA Kit |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human Rabies Virus Antibody IgG (RV-IgG) ELISA Kit |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human Rabies Virus Antibody IgG (RV-IgG) ELISA Kit |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human Rabies Virus Antibody IgG (RV-IgG) ELISA Kit |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Human rabies virus antibody IgG(RV-IgG) ELISA Kit |
Sunlong |
96 Tests |
EUR 468 |
|
Mutation Of information
GENLISA Human SARS-CoV-2 spike protein S1 mutation K417N (South Africa variant) Quantitative TITRATION ELISA |
KBVH015-40 |
Krishgen |
1 x 96 wells |
EUR 660 |
SARS-CoV-2 Spike B.1.1.7 Mutation RBD Domain (UK Variant, 100ug) |
BSV-COV-PR-72 |
BioServUK |
100 ug |
EUR 620 |
Description: SARS-CoV-2 Spike B.1.1.7 Mutation RBD Domain (UK Variant, 100ug) |
SARS-CoV-2 Spike B.1.351 Mutation RBD Domain (South African Variant, 100ug) |
BSV-COV-PR-74 |
BioServUK |
100 ug |
EUR 620 |
Description: SARS-CoV-2 Spike B.1.351 Mutation RBD Domain (South African Variant, 100ug) |
SARS-CoV-2 Spike P.1 Mutation RBD Domain (Brazil Variant, 100ug) |
BSV-COV-PR-76 |
BioServUK |
100 ug |
EUR 620 |
Description: SARS-CoV-2 Spike P.1 Mutation RBD Domain (Brazil Variant, 100ug) |
GENLISA Human SARS-CoV-2 spike protein RBD mutation K417N (South Africa variant) Quantitative TITRATION ELISA |
KBVH015-39_ |
Krishgen |
1 x 96 wells |
EUR 660 |
SARS-CoV-2 Spike Protein RBD (L452Q and F490S Mutations) |
abx620077-100g |
Abbexa |
100 µg |
EUR 287.5 |
SARS-CoV-2 Spike Protein RBD (L452Q and F490S Mutations) |
abx620077-1mg |
Abbexa |
1 mg |
EUR 1700 |
SARS-CoV-2 Spike Protein RBD (L452Q and F490S Mutations) |
abx620077-200g |
Abbexa |
200 µg |
EUR 412.5 |
SARS-CoV-2 Spike Protein RBD (E484K and S494P Mutations) |
abx620080-100g |
Abbexa |
100 µg |
EUR 287.5 |
SARS-CoV-2 Spike Protein RBD (E484K and S494P Mutations) |
abx620080-1mg |
Abbexa |
1 mg |
EUR 1700 |
SARS-CoV-2 Spike Protein RBD (E484K and S494P Mutations) |
abx620080-200g |
Abbexa |
200 µg |
EUR 412.5 |
GENLISA Human SARS-CoV-2 spike protein RBD mutation E484K (South Africa/Brazil variant) Quantitative TITRATION ELISA |
KBVH015-38_ |
Krishgen |
1 x 96 wells |
EUR 660 |
GENLISA Human SARS-CoV-2 spike protein RBD mutation N501Y (UK/South Africa/Brazil variant) Quantitative TITRATION ELISA |
KBVH015-36_ |
Krishgen |
1 x 96 wells |
EUR 660 |
GENLISA Human SARS-CoV-2 spike protein S1 mutation (UK variant) (HV69-70 deletion, N501Y, D614G) Quantitative TITRATION ELISA |
KBVH015-37 |
Krishgen |
1 x 96 wells |
EUR 660 |
Human SARS-CoV-2 Spike RBD Neutralization Antibody (N501Y Mutation Ab) ELISA Kit |
abx395194-1mg |
Abbexa |
1 mg |
EUR 687.5 |
Human SARS-CoV-2 Spike RBD Neutralization Antibody (E484K Mutation Ab) ELISA Kit |
abx395197-100g |
Abbexa |
100 µg |
EUR 687.5 |
SARS-CoV-2 Spike Protein RBD (R346K, E484K, N501Y, D614G and P681H Mutations) |
abx620079-100g |
Abbexa |
100 µg |
EUR 287.5 |